WO2013122304A1 - Composition for repelling insects comprising ir 3535 derivative as active ingredient - Google Patents

Composition for repelling insects comprising ir 3535 derivative as active ingredient Download PDF

Info

Publication number
WO2013122304A1
WO2013122304A1 PCT/KR2012/008991 KR2012008991W WO2013122304A1 WO 2013122304 A1 WO2013122304 A1 WO 2013122304A1 KR 2012008991 W KR2012008991 W KR 2012008991W WO 2013122304 A1 WO2013122304 A1 WO 2013122304A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
test
present
cinnamon
repellent
Prior art date
Application number
PCT/KR2012/008991
Other languages
French (fr)
Korean (ko)
Inventor
이삼빈
이인선
김배환
유미희
박성진
이진호
박민주
김지은
이지훈
Original Assignee
계명대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 계명대학교 산학협력단 filed Critical 계명대학교 산학협력단
Publication of WO2013122304A1 publication Critical patent/WO2013122304A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46N-acyl derivatives
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • A01N37/20Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/24Lauraceae [Laurel family], e.g. laurel, avocado, sassafras, cinnamon or camphor

Definitions

  • the present invention relates to a layered repellent composition, especially a mosquito repellent composition, comprising an IR 3535 derivative as an active ingredient.
  • mosquito repellents are used to protect individuals instead of insecticides that are restricted for use outdoors. It is mainly used in the formulation of aerosols, liquids, or lotions. Representative repellents are divided into synthetic compounds and natural compounds.
  • the main component of the mosquito repellents are organophosphate-based pesticides and Pierre droids and components and the most widely used worldwide DEETXN, N-diethyl- ntl- uamide) o This - the year 1964 - - o - the United States - Military It is used as a commodity. It is spread and used all over the world.
  • the present inventors have tried to develop insect repellents which are harmless to the human body and have high repellent activity against plows, especially mosquitoes.
  • the present invention has been completed by confirming that the IR 3535 derivative is harmless to the human body and has an excellent pollinating effect, particularly mosquito repelling effect.
  • an object of the present invention to provide an insect repellent composition. It is another object of the present invention to provide a cosmetic composition for repelling nadir.
  • the present invention provides an insect repellent composition comprising the compound of formula 1 as an active ingredient:
  • the present inventors endeavored to develop a layered repellent which is harmless to the human body and has a high repellent activeol against the layered layer, particularly mosquito.
  • the present invention was completed by confirming that the compound of Chemical Formula 1, which is an IR 3535 derivative, is harmless to the human body and has an excellent pollinating effect, particularly mosquito repelling effect.
  • the compound of Formula 1 as the IR 3535 derivative may be chemically synthesized from IR 3535.
  • IR 3535 derivative can utilize various chemical synthesis methods known in the art.
  • IR 3535 a precursor, is treated with acetic acid chloride and pyridine, reacted under reduced pressure, and then purified by chromatography.
  • the compound of formula 1 of the present invention exhibits a remarkable mosquito repellent effect (Table 3) and does not cause skin irritation or skin sensitization when applied to the skin (Tables 19 and 24).
  • the content of the compound of Chemical Formula 1 is 0.1-30% by weight, preferably 0.1-25% by weight, and more preferably, based on the total weight of the insect repellent composition of the present invention. 1-20% by weight), still more preferably 1-15% by weight, most preferably 1-10% by weight.
  • the goncheung of the invention mosquitoes, flies, ants, bees, crickets, norinjae, fan worms, fleas, beetles, and mole or cockroaches, preferably mosquitoes, ⁇ flies, ants, bees, Fanworms or fleas, more preferably mosquitoes, flies, ants or bees, most preferably mosquitoes.
  • Cinnamon supercritical oil included in the composition of the present invention may be prepared by a supercritical fluid extraction process. Cinnamomum verum, a raw material for supercritical extraction, is crushed to form a powder of a suitable size. Supercritical that can be used in the method of the present invention
  • the extraction vessel can be controlled in temperature and pressure, and is not particularly limited as long as it is a vessel configured to be in contact with the extraction raw material and the supercritical fluid.
  • the supercritical fluid used in the present invention includes various supercritical fluids commonly used in the art, and preferably water or carbon dioxide is used.
  • the co-solvent used with the supercritical fluid includes a polar solvent commonly used in the art, preferably alcohol, water, ethylene glycol, polyethylene glycol, propylene carbonate, formic acid, acetic acid, aceto Nitrile, chlorodifluoromethane or mixtures thereof, more preferably methane, ethanol, propanol, 1-
  • a polar solvent commonly used in the art, preferably alcohol, water, ethylene glycol, polyethylene glycol, propylene carbonate, formic acid, acetic acid, aceto Nitrile, chlorodifluoromethane or mixtures thereof, more preferably methane, ethanol, propanol, 1-
  • 15 is an alcohol selected from the group consisting of nucleanol, 2-methoxyethanol and combinations thereof, even more preferably methanol or ethanol, most preferably ethane.
  • the pressure in the supercritical extraction is 100-500 bar, more preferably 200-400 bar, most preferably 20 300-400 bar.
  • the temperature in the supercritical extraction is 10-10CTC, more preferably 30 ° C-70 ° C, even more preferably 30-50 ° C, most preferably 30-40 ° C.
  • the cinnamon supercritical oil is obtained by supercritical extraction of 25 cinnamon at a temperature of 30-40 ° C and a pressure of 200-400 bar.
  • the content of cinnamon supercritical oil with respect to the total weight of the insect repellent composition of the present invention is 0.1-25% by weight, preferably 0.1-20% by weight, more preferably 1 -20 wt%, even more preferably wt % , most preferably wt %
  • the present invention provides a composition for insect repellent Cosmetically effective amount; And a cosmetically acceptable carrier.
  • Ingredients included in the cosmetic composition of the present invention as an active ingredient includes components commonly used in cosmetic compositions in addition to the mosquito repellent composition, for example, conventional supplements such as stabilizers, solubilizers, vitamins, pigments and flavors, and Carrier.
  • the cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing It may be formulated as an oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, nutrition lotion, nutrition cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.
  • the carrier components include animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide. Can be used.
  • lactose When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, and in particular, in the case of spray, additionally chlorofluorohydrocarbon, Propellant such as propane / butane or dimethyl ether.
  • a solvent, a solubilizer or an emulsifier is used as the carrier component, for example, water, ethane, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol oil and glycerol are aliphatic esters, polyethylene glycols or fatty acid esters of sorbitan.
  • the carrier component is water, ethanol or a liquid diluent such as propylene glycol, ethoxylated isostearal-alcohol, polyoxyethylene sorbide ester and polyoxyethylene sorbitan.
  • Suspending agents such as esters, microcrystalline cellulose, aluminum metahydroxy bentonite, agar or tracant and the like can be used.
  • the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, an isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide.
  • the present invention provides a tomb layer avoidance method comprising the step of applying the insect repellent cosmetic composition of the present invention to the skin.
  • the present invention provides a method for avoiding insects, comprising applying the insect repellent composition composition of the present invention to a region to obtain a barrier effect.
  • the present invention provides an insect repellent composition
  • a compound of Formula 1 as an active ingredient as an IR 3535 derivative.
  • the present invention provides a tonic layer avoiding composition comprising the compound of formula 1 and cinnamon supercritical oil as an active ingredient.
  • composition of the present invention has excellent fragrance and sustainability, and exhibits a remarkable ⁇ excess layer avoiding effect.
  • the present invention provides a tortilla-repellent cosmetic composition.
  • the present invention provides a method for evacuating a stratum layer comprising applying a stratum layer avoidance cosmetic composition to the skin.
  • the present invention provides a method for avoiding insects, comprising applying to the area to obtain a layering effect.
  • 1 is a schematic diagram of a kennel produced to confirm the mosquito repelling effect of the test substance.
  • Figure 2 is a diagram showing the chemical structural formula of the IR 3535 derivative (LJH-1-58) which is a compound of formula 1 of the present invention.
  • Figure 3 is a diagram showing the eye drops and cleaning process of the test material in the eye irritation test for the test material.
  • Figure 4 is a diagram showing the eye film stimulation test results for the test substance.
  • 5 is a diagram showing the treatment procedure in the skin primary stimulation test for the test substance.
  • Figure 6 is a diagram showing the skin primary stimulation test results for the test substance.
  • 7 is a diagram showing the procedure of treatment in the skin sensitization test for the test substance.
  • FIG. 8 is a diagram showing a skin sensitization test result for a test substance.
  • the mosquitoes used in this experiment were collected and prepondered oil layers of Aedes albopictus and Cx. Pi pi ens pal lens. The temperature was 25-28 ° C, the humidity was 75-95%, the light condition was 16: 8 (L: D), and 10% sugar water was supplied, and SD rats (4 weeks old) were supplied for vampire blood, and the egg mass was 10
  • the mosquitoes were collected by dividing them into small boxes of X 10 X 10 cm, supplied with distilled water daily to increase the diet by distinguishing the larvae at each growth stage.
  • the pupa was delivered daily and raised in a stratified breeding ground (40 ⁇ 30 ⁇ 20) (FIG. 1). The stratification was separated by mating according to the growth cycle to maintain vampire force.
  • Bio assay Arm—in—cage test
  • Avoidance experiment was made to expose only part of the arm and protect the rest of the hand by connecting a cloth to a box of 40, 30 and 30 cm in height.
  • Evasion test was performed by spinning 50 mated females over 5 days of age in the evacuation box, and fasting by stopping 10% sugar water supply 6-8 hours before the experiment.
  • the white beetle mosquito is a species that can absorb 24 hours, but the most active time was observed at 10 am and 8 pm, respectively.
  • the experiment was conducted using only red illumination, a wavelength that mosquitoes could not recognize. During the experiment, the temperature was 27 ⁇ 1 ° C, the relative humidity was 75 ⁇ 5%, and the exposed areas were exposed for 5 minutes for each sample, and 1 mL of the sample was evenly applied to the exposed areas.
  • the mosquitoes were changed every time according to the sample, and the experiment was repeated three times, and 24% DEET was used as a control. The number of bites was counted for 5 seconds or more landing mosquito bites.
  • Methyl acrylate (2.40 g, 2.73 X 10 "2 moL) was dissolved in 5 mL of acetonitrile, and n-butylamine (1 g, 1.36 X 10 " 2 moL) was added thereto at 120 ° C and 70 W.
  • the microwave reaction was allowed for 30 minutes.
  • the solvent was removed by distillation under reduced pressure to obtain 3- (butylamino) propanoic acid methyl ester in 96.4% yield (2.06 g).
  • Supercritical extraction includes the supercritical extraction unit Waters AD-RC 08 (Waters CO.,
  • the extraction temperature was fixed at 35 ° C., extraction time was 120 minutes, and the pressure was set to 200, 300, 400 bar and extracted under three different conditions.
  • the rare extract was concentrated in a rotary vacuum concentrator (EYELA Co., Tokyo, Japan) at 40 ° C and used for the experiment.
  • Example 1 mosquito evasion test (Semi—field test)
  • Cage B has holes with a diameter of 20 cm on each side to allow mosquitoes to move in cage A and cage C.
  • Table 1 shows the results of observation of repellent activity on the LJH-1-58 at 5% and 10% concentration of DEET at 24%. After 1-2 minutes, 1OT of LJH-1-58 showed high repelling force, and it was confirmed that repelling force persisted even after 4-5 minutes. The similarity of 10% UH-1-58 and 24% DEET avoidance suggests that LJH-1-58 could be used as a novel compound of IR 3535 to replace DEET. In addition, white-row mosquitoes showed about 90% repellency (Table 2). LJH-1-58 can be applied to both mosquitoes.
  • IR 3535 derivative (LJH-1-58) avoids white mosquitoes
  • Cinnamon supercritical oil 400 bar, 35 ° C.
  • Cinnamon supercritical oil 400 bar, 35 ° C
  • 1% + 10% IR 3535 Cinnamon supercritical oil
  • mice Six-week-old ICR mice were obtained (Hyochang Science, Korea) and administered at seven weeks of age. A total of 18 animals (9 males and 9 females) were used for the experiments, and they had a weekly quarantine and adaptation period, and were observed daily during this period, and only healthy animals were used for the test. Test Methods
  • Animals were screened based on body weight during quarantine and red-eye periods, and then groups were constructed so that the average weight of each group was as evenly as possible by random method based on body weight on the day of group separation. The number of digits per group was assigned to three male and female experiments. Individual identification was by tail labeling and 3 animals per cage were housed. After fasting (about 14-16 hours) the day before administration, the test substance was orally administered using sonde.
  • the group administered 100% of the repellent showed no abnormality on the day of administration, but all died 1 day after administration.
  • the repellent group and the solvent-administered group did not show any specific clinical symptoms or died animals during the experiment (Table 5-10).
  • repellents are hayeoteumeuro when administered with, 50% dilution 10 ml / kg was our both when administered as a 100% stock solution toxicity test danhui orally administered 10 ml / kg, all survived, LD 50 of the test substance Value is estimated at 5-10 ml / kg based on 100% stock solution.
  • mice with no abnormalities in the eye such as corneal damage are selected after eye examination, and healthy animals with no abnormalities in clinical and weight gain and healthy condition are determined by weight and age on the day of group separation.
  • groups were composed so that the average weight of each group was equal. Two out of four eyes were given the test substance in the right eye, and the left eye was left untreated. The other two eyes were given the test group after the instillation of the test substance in the right eye and PEG-400, the left eye in the control group. (FIG. 3).
  • Test substance was diluted in PEG-400 and administered 0.1 ml per eye at 10% concentration. Washing eyes were thoroughly washed with warm physiological saline 30 seconds after eye drops. Observation and Inspection Items
  • AOI acute ocular irritation index
  • test substance was prepared at an appropriate concentration, 0.5 ml of each site was applied, and closed patch for 24 hours (FIG. 5). Observation and Inspection Items
  • the skin primary stimulation index ( ⁇ . ⁇ . ⁇ .) was calculated by erythema and edema grade at 24 hours and 72 hours after application of test substance.
  • the mean of erythema score and edema score were calculated for each of the abrasion site and the non-brain site, and the results were judged by the skin primary stimulation index based on the skin primary stimulation index as the average value of the results at 24 hours and at 72 hours. It was.
  • Hartley albino guinea pigs weighing 250-300 g were purchased (Samtaco Korea). Healthy animals with a week-long quarantine and red-eye period during which weight gain and general symptoms were not removed were used for the test. After removing the quarantine and adaptation period, the back of the animal is epilated to select healthy animals with good skin condition. Based on the weight on the day of separation, the groups were configured so that the average body weight was as even as possible. Test Methods
  • Induction was performed using the upper part of the back (the upper part of the shoulders) at 3 x 3 cm hair removal 4 hours before the test. The hair was removed to a size of 4 ⁇ 6 cm and used after removing the remaining hair with an electric razor on the test day.
  • Primary induction was intradermal injection of 0.1 ml of sample, FCA, and sample + FCA into the guinea pig scapula in each test group. Secondary induction is a week after depilation of the same site of FCA injection, 10% SLS (solvent: petrolatum) is applied to the injection site, and after 24 hours, a patch of 1.5 X 1.5 cm in diameter in which 0.1 ml of the test substance is administered to the same site.
  • SLS solvent: petrolatum

Abstract

The present invention relates to an insect-repelling composition comprising an IR 3535 derivative as an active ingredient. Also, the present invention provides an insect-repelling composition comprising an IR 3535 derivative and a cinnamon supercritical-based oil as active ingredients. The composition of the present invention exhibits a marked insect-repelling effect since the composition has outstanding aromatic properties and durability.

Description

- 【명세서】  - 【Specification】
【발명의 명칭】  [Name of invention]
IR 3535 유도체를 유효성분으로 포함하는 곤층 기피용 조성물 【기술분야】  Composition for avoiding stratum corneum containing IR 3535 derivative as an active ingredient
본 발명은 IR 3535 유도체를 유효성분으로 포함하는 곤층 기피용 특히 모기 기피용 조성물에 관한 것이다.  The present invention relates to a layered repellent composition, especially a mosquito repellent composition, comprising an IR 3535 derivative as an active ingredient.
【배경기술】 Background Art
모기는 지구상에 약 3, 500종이 알려져 있고, 한국에서는 9속 55종이 기록되어 있다. 이러한 모기에 대한 피해는 1974년 아프리카 에티오피아에서 발견된 오스트랄로피테쿠스 유골의 사인이 말라리아라 (malaria)라는 추론이 있다. 모기는 일반적으로 교미 후 암컷 성충의 난을 성숙시키기 위하여 동물에서 단백질을 얻기 위한 흡혈 활동을 하게 되며, 흡혈부위에 알레르기의 원인이 되는 타액 (saliva)을 분비하게 된다. 이때 모기의 침샘 내 병원성 바이러스 균이 잠복된 경우 사람에게 질병을 매개하게 되는데, 그 대표적인 질병이 뎅기열 (dengue hemorrhagic fever), 뇌염 (encephal itis) , 황열병 (yellow fever) 등이다. 말라리아와 뎅기열에 의한 사망 인구는 매년 백만 명 이상으로 1일 기준 3, 000명 이상의 사람들이 목숨을 잃고 있으며, 그 중 대부분이 어린 아동인 것으로 보고되고 있다. 오늘날에는 과학의 발달로 인한 환경오염과 지구 About 3,500 species of mosquitoes are known on the planet, and 9 genera and 55 species are recorded in Korea. The damage to these mosquitoes is inferred that the cause of the Australopithecus remains, found in Ethiopia, Africa in 1974, is malaria. Mosquitoes are generally vampireic to obtain proteins from animals to mature eggs of adult females after mating, and secrete saliva that causes allergy to the vampire. At this time, when the pathogenic virus bacteria in the salivary glands of the mosquitoes are latent, the disease is mediated to humans. The typical diseases are dengue hemorrhagic fever, encephal itis, and yellow fever. Malaria and dengue deaths affect more than one million people per year, killing more than 3,000 people a day, most of which are reported to be young children. Today, environmental pollution and the earth caused by the development of science
,온난화로 모기의 출현 기간 및 발생빈도가 더욱 증가하고 있다. Due to warming, the period and frequency of occurrence of mosquitoes are increasing.
이러한 모기를 생활공간으로부터 방제하기 위하여 이용된 방법 중 하나가 기피제이다. 모기 기피제는 야외에서의 사용이 제한되는 살충제대신 개인의 보호방법으로 이용된다. 주로 에어로졸이나, 액체, 로션의 제형으로 이용되고 있으며, 대표적인 기피성분은 합성 화합물 (synthet ic .compounds)와 천연성분 (natural compounds)으로 나눈다. 모기 기피제의 주요 성분으로는 유기인계 및 피레드로이드계 살충제를 사용하고 있으며 세계적으로 가장 널리 사용되는 성분 DEETXN, N-diethyl- n t l— uamide)ᅩ이 -다 1964—년——미국의—―군용보급품으로ᅳ사용되―어一전一 세계적으로 보급되어 사용되고 있다. 하지만, 인체의 서로 다른 부위에 적용했을 때, 시간 경과에 따른 유효 잔존량이 다르고 사람의 피부를 통한 침투율이 높고, 경구독성 때문에 임산부나 어린아이 등에서 아직 안정성이 입증되지 않았다. 이러한 화학적 합성 모기 기피제에 대한 문제점을 보완하기 위해서 천연성분인 식물정유를 이용한 기피제의 연구가 진행되고 있지만 지속성이 짧고, 기피효과를 위해서 많은 양을 첨가해야 되는 문제점이 있다. 본 명세서 전체에 걸쳐 다수의 논문 및 특허문헌이 참조되고 그 인용이 표시되어 있다. 인용된 논문 및 특허문헌의 개시 내용은 그 전체로서 본 명세서에 참조로 삽입되어 본 발명이 속하는 기술 분야의 수준 및 본 발명의 내용이 보다 명확하게 설명된다. One of the methods used to control these mosquitoes from the living space is the repellent. Mosquito repellents are used to protect individuals instead of insecticides that are restricted for use outdoors. It is mainly used in the formulation of aerosols, liquids, or lotions. Representative repellents are divided into synthetic compounds and natural compounds. The main component of the mosquito repellents are organophosphate-based pesticides and Pierre droids and components and the most widely used worldwide DEETXN, N-diethyl- ntl- uamide) o This - the year 1964 - - o - the United States - Military It is used as a commodity. It is spread and used all over the world. But in different parts of the body When applied, the effective residual amount over time, high penetration rate through human skin, and oral toxicity have not yet proved stable in pregnant women and children. In order to supplement the problems with the chemical synthetic mosquito repellents, research on repellents using plant essential oils, which are natural ingredients, has been conducted. Throughout this specification, many papers and patent documents are referenced and their citations are indicated. The disclosures of cited papers and patent documents are incorporated herein by reference in their entirety, and the level of the technical field to which the present invention belongs and the contents of the present invention are more clearly explained.
【발명의 내용】 [Content of invention]
【해결하려는 과제】  [Problem to solve]
본 발명자들은 인체에 무해하면서 곤층, 특히 모기에 대해 높은 기피활성을 갖는 곤충 기피제를 개발하고자 노력하였다. 그 결과, IR 3535 유도체가 인체에 무해하면서도 우수한 곤층, 특히 모기 기피 효과를 가진다는 것을 확인함으로써, 본 발명을 완성하게 되었다.  The present inventors have tried to develop insect repellents which are harmless to the human body and have high repellent activity against plows, especially mosquitoes. As a result, the present invention has been completed by confirming that the IR 3535 derivative is harmless to the human body and has an excellent pollinating effect, particularly mosquito repelling effect.
따라서, 본 발명의 목적은 곤충 기피용 조성물을 제공하는데 있다. 본 발명의 다른 목적은 곤층 기피용 화장료 조성물을 제공하는데 있다.  Accordingly, it is an object of the present invention to provide an insect repellent composition. It is another object of the present invention to provide a cosmetic composition for repelling nadir.
본 발명의 또 다른 목적은 곤층 기피 방법을 제공하는데 있다. 본 발명의 다른 목적 및 이점은 하기의 발명의 상세한 설명 및 청구범위에 의해 보다 명확하게 된다 .  It is still another object of the present invention to provide a method for avoiding stagnation. Other objects and advantages of the present invention will become apparent from the following detailed description and claims.
【과제의 해결 수단】 [Measures of problem]
본 발명의 일 양태에 따르면, 본 발명은 다음 화학식 1의 화합물을 유효성분으로 포함하는 곤충 기피 (insect repellent) 조성물을 제공한다:
Figure imgf000005_0001
According to one aspect of the present invention, the present invention provides an insect repellent composition comprising the compound of formula 1 as an active ingredient:
Figure imgf000005_0001
본 발명자들은 인체에 무해하면서 곤층, 특히 모기에 대해 높은 기피활성올 갖는 곤층 기피제를 개발하고자 노력하였다. 그 결과, IR 3535 유도체인 상기 화학식 1의 화합물이 인체에 무해하면서도 우수한 곤층, 특히 모기 기피 효과를 가진다는 것을 확인함으로써, 본 발명을 완성하게 되었다. The present inventors endeavored to develop a layered repellent which is harmless to the human body and has a high repellent activeol against the layered layer, particularly mosquito. As a result, the present invention was completed by confirming that the compound of Chemical Formula 1, which is an IR 3535 derivative, is harmless to the human body and has an excellent pollinating effect, particularly mosquito repelling effect.
본 발명의 바람직한 구현예에 따르면, 상기 IR 3535 유도체로서의 상기 화학식 1의 화합물은 IR 3535로부터 화학적으로 합성할 수 있다.  According to a preferred embodiment of the present invention, the compound of Formula 1 as the IR 3535 derivative may be chemically synthesized from IR 3535.
IR 3535 유도체의 합성은 당업계에 공지된 다양한 화학적 합성 방법을 이용할 수 있다. 바람직하게는 선구 물질인 IR 3535에 염화아세트산 및 피리딘을 처리하여 반웅시키고, 감압여과 한 후 크로마토그래피로 정제하여 수득한다.  Synthesis of the IR 3535 derivative can utilize various chemical synthesis methods known in the art. Preferably, IR 3535, a precursor, is treated with acetic acid chloride and pyridine, reacted under reduced pressure, and then purified by chromatography.
본 발명의 바람직한 구현예에 따르면ᅳ 본 발명의 상기 화학식 1의 화합물은 현저한 모기 기피 효과 (표 3)를 나타내며, 피부에 적용하였을 때 피부 자극 또는 피부 감작을 유발시키지 않는다 (표 19, 24).  According to a preferred embodiment of the present invention the compound of formula 1 of the present invention exhibits a remarkable mosquito repellent effect (Table 3) and does not cause skin irritation or skin sensitization when applied to the skin (Tables 19 and 24).
본 발명의 바람직한 구현예에 따르면, 본 발명의 곤충 기피 조성물의 총 중량에 대하여 상기 화학직 1의 화합물의 함량은 0.1-30 중량 >이며, 바람직하게는 0.1-25 중량%이고, 보다 바람직하게는 1-20 중량 )이며, 보다 더 바람직하게는 1-15중량 %이고, 가장 바람직하게는 1-10중량 %이다.  According to a preferred embodiment of the present invention, the content of the compound of Chemical Formula 1 is 0.1-30% by weight, preferably 0.1-25% by weight, and more preferably, based on the total weight of the insect repellent composition of the present invention. 1-20% by weight), still more preferably 1-15% by weight, most preferably 1-10% by weight.
본 발명의 바람직한 구현예에 따르면, 본 발명의 곤층은 모기, 파리, 개미, 벌, 귀뚜라미, 노린재, 부채벌레, 벼룩, 풍뎅이, 사마귀 또는 바퀴벌레이며, 바람직하게는 모기, 파리, 개미, 벌, 부채벌레 또는 벼룩이고, 보다 바람직하게는 모기, 파리, 개미 또는 벌이며, 가장 바람직하게는 모기이다. According to a preferred embodiment, the goncheung of the invention mosquitoes, flies, ants, bees, crickets, norinjae, fan worms, fleas, beetles, and mole or cockroaches, preferably mosquitoes, flies, ants, bees, Fanworms or fleas, more preferably mosquitoes, flies, ants or bees, most preferably mosquitoes.
본 발ᅭ명—의—바람작한-구현예에—따르짠 7——본ᅳ발명—의— 조—성ᅳ물은一계꾀- 초임계 오일을 추가적으로 포함한다. 본 발명의 조성물에 포함되는 계피 초임계 오일은 기본적으로 초임계유체 추출 과정에 따라 제조될 수 있다. 초임계 추출의 원재료인 계피 (Cinnamomum verum)를 적합한 크기의 입자 분말 형태가 되도록 파쇄하여 사용한다. 본 발명의 방법에서 사용할 수 있는 초임계 7 ——The invention—of the invention—according to this invention's—desirable—implementation—contains additionally one super-critical oil. Cinnamon supercritical oil included in the composition of the present invention may be prepared by a supercritical fluid extraction process. Cinnamomum verum, a raw material for supercritical extraction, is crushed to form a powder of a suitable size. Supercritical that can be used in the method of the present invention
5 추출용기는 온도와 압력이 조절될 수 있으며, 추출원료와 초임계 유체가 접촉하도록 구성된 용기이면 특별히 한정되지 않는다. 5 The extraction vessel can be controlled in temperature and pressure, and is not particularly limited as long as it is a vessel configured to be in contact with the extraction raw material and the supercritical fluid.
본 발명에서 이용되는 초임계유체는 당업계에서 통상적으로 이용되는 다양한 초임계유체를 포함하며, 바람직하게는 물 또는 이산화탄소를 사용한다.  The supercritical fluid used in the present invention includes various supercritical fluids commonly used in the art, and preferably water or carbon dioxide is used.
10 상기 초임계유체와 함께 사용되는 보조용매는 당업계에서 통상적으로 이용되는 극성 용매를 포함하며, 바람직하게는 알코을, 물, 에틸렌 글라이콜, 폴리에틸렌글라이콜, 프로필렌카보네이트, 포름산, 아세트산, 아세토니트릴, 클로로디프루오로메탄 또는 이의 흔합물로 구성된 군으로부터 선택되며ᅳ 보다 바람직하게는 메탄을, 에탄올, 프로판올, 1- 10 The co-solvent used with the supercritical fluid includes a polar solvent commonly used in the art, preferably alcohol, water, ethylene glycol, polyethylene glycol, propylene carbonate, formic acid, acetic acid, aceto Nitrile, chlorodifluoromethane or mixtures thereof, more preferably methane, ethanol, propanol, 1-
15 핵사놀, 2-메톡시에탄올 및 그의 조합으로 구성된 군으로부터 선택되는 알코올이고, 보다 더 바람직하게는 메탄올 또는 에탄올이며, 가장 바람직하게는 에탄을이다. 15 is an alcohol selected from the group consisting of nucleanol, 2-methoxyethanol and combinations thereof, even more preferably methanol or ethanol, most preferably ethane.
본 발명의 바람직한 구현예에 따르면, 상기 초임계 추출에서의 압력은 100-500 bar, 보다 바람직하게는 200-400 bar, 가장 바람직하게는 20 300-400 bar이다.  According to a preferred embodiment of the invention, the pressure in the supercritical extraction is 100-500 bar, more preferably 200-400 bar, most preferably 20 300-400 bar.
본 발명의 다른 바람직한 구현 예에 따르면, 상기 초임계 추출에서의 온도는 10-10CTC, 보다 바람직하게는 30°C-70°C, 보다 더 바람직하게는 30- 50°C이고, 가장 바람직하게는 30-40°C이다. According to another preferred embodiment of the invention, the temperature in the supercritical extraction is 10-10CTC, more preferably 30 ° C-70 ° C, even more preferably 30-50 ° C, most preferably 30-40 ° C.
본 발명의 바람직한 구현예에 따르면, 상기 계피 초임계 오일은 25 계피를 온도 30-40°C 및 압력 200-400 bar에서 초임계 추출하여 수득한다. According to a preferred embodiment of the present invention, the cinnamon supercritical oil is obtained by supercritical extraction of 25 cinnamon at a temperature of 30-40 ° C and a pressure of 200-400 bar.
본 발명의 바람직한 구현예에 따르면, 본 발명의 곤충 기피용 조성물의 총 중량에 대하여 계피 초임계 오일의 함량은 0.1-25 중량 %이며, 바람직하게는 0.1-20 중량 %이고, 보다 바람직하게는 1-20 중량 %이며, 보다 더 바람직하게는 중량 %이고, 가장 바람직하게는 중량%이다ᅳ According to a preferred embodiment of the present invention, the content of cinnamon supercritical oil with respect to the total weight of the insect repellent composition of the present invention is 0.1-25% by weight, preferably 0.1-20% by weight, more preferably 1 -20 wt%, even more preferably wt % , most preferably wt %
-30- - 본 발명의 또 다른 양태에 따르면, 본 발명은 곤충 기피용 조성물의 화장품학적 유효량; 및 화장품학적으로 허용되는 담체를 포함하는 곤층 기피용 화장료 조성물을 제공한다. According to another aspect of the invention, the present invention provides a composition for insect repellent Cosmetically effective amount; And a cosmetically acceptable carrier.
본 발명의 화장료 조성물에 포함되는 성분은 유효 성분으로서 상기 모기 기피용 조성물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함하며, 예컨대 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함한다.  Ingredients included in the cosmetic composition of the present invention as an active ingredient includes components commonly used in cosmetic compositions in addition to the mosquito repellent composition, for example, conventional supplements such as stabilizers, solubilizers, vitamins, pigments and flavors, and Carrier.
본 발명의 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어 , 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제 -함유 클린싱, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 유연 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 클렌징 크림, 클렌징 포음, 클렌징 워터, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.  The cosmetic composition of the present invention may be prepared in any formulation commonly prepared in the art, for example, solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing It may be formulated as an oil, powder foundation, emulsion foundation, wax foundation and spray, but is not limited thereto. More specifically, it may be prepared in the form of a flexible lotion, nutrition lotion, nutrition cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, spray or powder.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀를로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.  When the formulation of the present invention is a paste, cream or gel, the carrier components include animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide. Can be used.
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로폴루오로히드로카본, 프로판 /부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.  When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used, and in particular, in the case of spray, additionally chlorofluorohydrocarbon, Propellant such as propane / butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄을, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세를 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.  When the formulation of the present invention is a solution or emulsion, a solvent, a solubilizer or an emulsifier is used as the carrier component, for example, water, ethane, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1,3-butylglycol oil and glycerol are aliphatic esters, polyethylene glycols or fatty acid esters of sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 ᅵ프로필렌 글리콜과 같은 액상의 희석제, 에특실화 이소스테아럴- 알코을, 폴리옥시에틸렌 소르비를 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀를로오스, 알루미늄 메타히드록시드 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다 . When the formulation of the present invention is a suspension, the carrier component is water, ethanol or a liquid diluent such as propylene glycol, ethoxylated isostearal-alcohol, polyoxyethylene sorbide ester and polyoxyethylene sorbitan. Suspending agents such as esters, microcrystalline cellulose, aluminum metahydroxy bentonite, agar or tracant and the like can be used.
본 발명의 제형이 계면-활성제 함유 클린징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체 , 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이 , 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄을아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세를 지방산 에스테르 등이 이용될 수 있다.  When the formulation of the present invention is a surfactant-containing cleansing agent, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, an isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide. Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters.
본 발명의 다른 양태에 따르면, 본 발명은 상기 본 발명의 곤충 기피용 화장료 조성물을 피부에 도포하는 단계를 포함하는 곤층 기피 방법을 제공한다.  According to another aspect of the present invention, the present invention provides a tomb layer avoidance method comprising the step of applying the insect repellent cosmetic composition of the present invention to the skin.
본 발명의 또 다른 양태에 따르면, 본 발명은 상기 본 발명의 곤충 기피 조성물 조성물을 방층 효과를 얻고자 하는 영역에 적용 (applying) 하는 단계를 포함하는 곤충 기피 방법을 제공한다.  According to still another aspect of the present invention, the present invention provides a method for avoiding insects, comprising applying the insect repellent composition composition of the present invention to a region to obtain a barrier effect.
【발명의 효과】 【Effects of the Invention】
본 발명의 특징 및 이점을 요약하면 다음과 같다:  The features and advantages of the present invention are summarized as follows:
( i ) 본 발명은 IR 3535 유도체로서의 화학식 1의 화합물을 유효성분으로 포함하는 곤충 기피 조성물을 제공한다.  (i) The present invention provides an insect repellent composition comprising a compound of Formula 1 as an active ingredient as an IR 3535 derivative.
(ϋ) 본 발명은 화학식 1의 화합물 및 계피 초임계 오일을 유효성분으로 포함하는 곤층 기피 조성물을 제공한다.  (iii) The present invention provides a tonic layer avoiding composition comprising the compound of formula 1 and cinnamon supercritical oil as an active ingredient.
(iii) 본 발명의 조성물은 우수한 방향성 및 지속력을 갖고 있어 현저한≤과곤층 기피 효과를 나타낸다.  (iii) The composition of the present invention has excellent fragrance and sustainability, and exhibits a remarkable ≤ excess layer avoiding effect.
(iv) 본 발명은 곤층 기피 화장료 조성물을 제공한다.  (iv) The present invention provides a tortilla-repellent cosmetic composition.
(V) 본 발명은 곤층 기피 화장료 조성물을 피부에 도포하는 단계를 포함하는 곤층 기피 방법을 제공한다.  (V) The present invention provides a method for evacuating a stratum layer comprising applying a stratum layer avoidance cosmetic composition to the skin.
(vi) 본 발명은 곤층 기피 조성물을 방층 효과를 얻고자 하는 영역에 적용 (applying) 하는 단계를 포함하는 곤충 기피 방법을 제공한다. 【도면의 간단한 설명】 (vi) The present invention provides a method for avoiding insects, comprising applying to the area to obtain a layering effect. [Brief Description of Drawings]
도 1은 시험물질의 모기 기피 효과를 확인하기 위해 제작한 사육장에 대한 모식도이다.  1 is a schematic diagram of a kennel produced to confirm the mosquito repelling effect of the test substance.
도 2는 본 발명의 본 발명의 화학식 1의 화합물인 IR 3535 유도체 (LJH-1-58)의 화학 구조식을 나타낸 그림이다.  Figure 2 is a diagram showing the chemical structural formula of the IR 3535 derivative (LJH-1-58) which is a compound of formula 1 of the present invention.
도 3은 시험물질에 대한 안점막자극시험에서 시험물질의 점안 및 세척 과정을 나타낸 그림이다.  Figure 3 is a diagram showing the eye drops and cleaning process of the test material in the eye irritation test for the test material.
도 4는 시험물질에 대한 안점막자극시험 결과를 나타낸 그림이다. 도 5는 시험물질에 대한 피부 일차자극시험 시 처치 과정을 나타낸 그림이다.  Figure 4 is a diagram showing the eye film stimulation test results for the test substance. 5 is a diagram showing the treatment procedure in the skin primary stimulation test for the test substance.
도 6은 시험물질에 대한 피부 일차자극시험 결과를 나타낸 그림이다. 도 7은 시험물질에 대한 피부 감작성 시험 시 처치 과정을 나타낸 그림이다.  Figure 6 is a diagram showing the skin primary stimulation test results for the test substance. 7 is a diagram showing the procedure of treatment in the skin sensitization test for the test substance.
도 8은 시험물질에 대한 피부 감작성 시험 결과를 나타낸 그림이다.  8 is a diagram showing a skin sensitization test result for a test substance.
【발명을 실시하기 위한 구체적인 내용 1 [Specific contents 1 to carry out invention
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다. 실시예  Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention more specifically, it will be apparent to those skilled in the art that the scope of the present invention is not limited by these examples in accordance with the gist of the present invention. . EXAMPLE
재료 및 방법  Materials and methods
시험곤충  Test insect
본 실험에 사용된 모기는 흰줄숲모기 (Aedes albopictus)와 빨간집모기 (Cx. pi pi ens pal lens)의 유층을 채집 및 분양 받아 누대 사육하였다. 온도 25-28°C, 습도는 75-95%, 광조건은 16:8(L:D)를 유지하면서 10% 설탕물을 공급하고 흡혈을 위해 SD 랫트 (4 주령)를 공급하였고, 난괴는 10 X 10 X 10 cm 의 작은 상자에 모기종류 별로 ᅳᅳ구분하여 수거하였고, 매일 증류수를 공급하면서 성장 단계별로 유충을- 구별하여 식이 (fish diet)를 증가시키면서 공급하였고, 최종으로 성장한 번데기는 매일 건져서 성층 사육장 (40 X 30 X 20) (도 1)에서 사육하였다. 성층은 성장주기에 따라 구분하여 교미시켜 흡혈력을 유지하였다. 생물 검정 (Arm—in—cage test) The mosquitoes used in this experiment were collected and prepondered oil layers of Aedes albopictus and Cx. Pi pi ens pal lens. The temperature was 25-28 ° C, the humidity was 75-95%, the light condition was 16: 8 (L: D), and 10% sugar water was supplied, and SD rats (4 weeks old) were supplied for vampire blood, and the egg mass was 10 The mosquitoes were collected by dividing them into small boxes of X 10 X 10 cm, supplied with distilled water daily to increase the diet by distinguishing the larvae at each growth stage. The pupa was delivered daily and raised in a stratified breeding ground (40 × 30 × 20) (FIG. 1). The stratification was separated by mating according to the growth cycle to maintain vampire force. Bio assay (Arm—in—cage test)
기피 실험은 가로 40, 세로 30, 높이 30 cm 규격의 상자에 천을 연결하여 손에서 팔 일부만을 노출 시키고 나머지 부분은 보호 할 수 있도록 제작하였다. 기피력 평가는 성층 주령 5 일 이상의 교미된 암컷 50 마리를 기피실험 상자에 방사하여 실험하였고, 실험 6-8시간 전 10%설탕물 공급을 중단하여 절식한 후, 실험 하였다. 흰즐숲모기의 경우는 24 시간 흡력이 가능한 종이지만 가장 활발한 시간을 관찰하여 오전 10 시 , 오후 8 시에 각각 실험하였고, 야행성인 빨간집모기는 오후 7 시 30 분에서 10 시 30 분 사이 암 조건하에서 모기가 인식할 수 없는 파장인 빨간색 조명만을 사용하여 실험하였다. 실험 시 온도는 27±1°C, 상대습도 75±5%, 노출부위는 시료 별로 각각 5 분씩 노출하였으며, 노출 부위에 1 mL 의 시료를 고르게 도포하였다. 모기는 샘플에 따라 매번 바꾸었으며 3 회 반복하여 실험하였고, 대조구로는 24% DEET를 사용하였다. 바이팅 횟수는 5초 이상 랜딩한 모기와 바이팅한 모기를 카운팅 하였다. Avoidance experiment was made to expose only part of the arm and protect the rest of the hand by connecting a cloth to a box of 40, 30 and 30 cm in height. Evasion test was performed by spinning 50 mated females over 5 days of age in the evacuation box, and fasting by stopping 10% sugar water supply 6-8 hours before the experiment. The white beetle mosquito is a species that can absorb 24 hours, but the most active time was observed at 10 am and 8 pm, respectively. The experiment was conducted using only red illumination, a wavelength that mosquitoes could not recognize. During the experiment, the temperature was 27 ± 1 ° C, the relative humidity was 75 ± 5%, and the exposed areas were exposed for 5 minutes for each sample, and 1 mL of the sample was evenly applied to the exposed areas. The mosquitoes were changed every time according to the sample, and the experiment was repeated three times, and 24% DEET was used as a control. The number of bites was counted for 5 seconds or more landing mosquito bites.
3- (뷰틸아미노)프로판산 메틸 에스터의 합성 Synthesis of 3- (butylamino) propanoic acid methyl ester
아크릴산 메틸 에스터 (2.40 g, 2.73 X 10"2 moL)를 아세토나이트릴 5 mL 에 녹인 후, n-뷰틸아민 (1 g, 1.36 X 10"2 moL)을 넣고 120°C, 70 W 의 조건에서 마이크로파 (microwave) 반응을 30 분 동안 시켰다. 감압증류로 용매를 제거하여 3- (뷰틸아미노)프로판산 메틸 에스터를 수율 96.4%(2.06g)로 얻었다. Methyl acrylate (2.40 g, 2.73 X 10 "2 moL) was dissolved in 5 mL of acetonitrile, and n-butylamine (1 g, 1.36 X 10 " 2 moL) was added thereto at 120 ° C and 70 W. The microwave reaction was allowed for 30 minutes. The solvent was removed by distillation under reduced pressure to obtain 3- (butylamino) propanoic acid methyl ester in 96.4% yield (2.06 g).
3- (N-뷰틸아세트아미노) 프로판산 메틸 에스터의 합성 (UHᅳ 1-58) Synthesis of 3- (N-butylacetamino) propanoic acid methyl ester (UH ′ 1-58)
3- (뷰틸아미노) 프로판산 메틸 에스터 (2.06 g, 1.29 X 10"2 moL)를 디클로로메테인 (DCM) 30 mL 에 녹인 후, 염화아세트산 (1.83 mL, 2.58 X 10'2 moL), 피리딘 3.21 mL, 3.87 X 10"2 moL)을 넣고 상온에서 1시간 교반시켰다. 반웅물을 감압여과 하여 얻어진 여과액을 물과 5% 구연산 용액으로 씻어 준 후, DMC 층을 무수 황산나트륨으로 처리하여 물을 제거하였다. 용매를 감압증류로 제거한 다음 핵세인과 에틸 아세테이트 (1:2)를 이용한 컬럼크로마토그래피로 정제하여 3-(N-뷰틸아세트아미노)프로판산 메틸 에스터 (도 2)를 수율 72.3%(1.88 g)로 얻었다. 3- (Butylamino) propanoic acid methyl ester (2.06 g, 1.29 X 10 "2 moL) was dissolved in 30 mL of dichloromethane (DCM), followed by acetic acid chloride (1.83 mL, 2.58 X 10 '2 moL), pyridine 3.21 mL, 3.87 X 10 "2 moL) was added and stirred at room temperature for 1 hour. The filtrate obtained by filtration under reduced pressure was washed with water and 5% citric acid solution, and then the DMC layer was treated with anhydrous sodium sulfate to remove water. Solvent After distillation under reduced pressure, the residue was purified by column chromatography using nucleine and ethyl acetate (1: 2) to give 3- (N-butylacetamino) propanoic acid methyl ester (FIG. 2) in a yield of 72.3% (1.88 g). .
¾ NMR(CDC13, 400MHz ) : δ 3.70(m, 3H), 3.59(m, 2H), 3.28(m, 2H), 5 2.62(m, 2H), 2.09(m, 3H), 1.55(m, 2H), 0.95(m, 3H)  ¾ NMR (CDC13, 400MHz): δ 3.70 (m, 3H), 3.59 (m, 2H), 3.28 (m, 2H), 5 2.62 (m, 2H), 2.09 (m, 3H), 1.55 (m, 2H ), 0.95 (m, 3H)
12C NMR(CDC13, 400MHz) : δ 176.68, δ 175.37, δ 49.29, δ 48.13, 546.27, δ 36.37, δ 34.86, δ 24.98, 523.83, δ 17.53 계피초임계오일의 제조 12 C NMR (CDC13, 400 MHz): Preparation of δ 176.68, δ 175.37, δ 49.29, δ 48.13, 546.27, δ 36.37, δ 34.86, δ 24.98, 523.83, δ 17.53 Cinnamon Supercritical Oil
10 초임계 추출에는 초임계 추출 장치 Waters AD-RC 08(Waters CO. , 10 Supercritical extraction includes the supercritical extraction unit Waters AD-RC 08 (Waters CO.,
Mil ford, MA, USA)를 사용하였다. 시료를 추출 용기에 300 g 을 넣어 이산화탄소 (C02)유속 : 보조용매유속 = 47.5 g/분 : 2.5 g/분으로 하여 총 유속 (이산화탄소유속 + 보조용매유속)은 50 g/분의 속도로 흘려주었고, 보조용매로는 HPLC급 에틸 알코을 (JT Baker Co., Phi 11 ipsburg, NJ, USA)를Mil ford, MA, USA). 300 g of the sample was placed in the extraction vessel, and the carbon dioxide (C0 2 ) flow rate: co-solvent flow rate = 47.5 g / min: 2.5 g / min. HPLC solvent ethyl alcohol (JT Baker Co., Phi 11 ipsburg, NJ, USA) was used.
15 사용하였다. 추출 온도는 35°C, 추출 시간은 120 분으로 고정하였으며, 압력을 200, 300, 400 bar 로 하여 압력이 다른 3 가지 조건에서 추출하였다. 희수된 추출물을 40°C에서 회전진공농축기 (EYELA Co., Tokyo, Japan)를 이용하여 농축한 후 실험에 사용하였다. 15 was used. The extraction temperature was fixed at 35 ° C., extraction time was 120 minutes, and the pressure was set to 200, 300, 400 bar and extracted under three different conditions. The rare extract was concentrated in a rotary vacuum concentrator (EYELA Co., Tokyo, Japan) at 40 ° C and used for the experiment.
20 실험결과 20 Experiment Results
실시예 1 : 모기 기피 실험 (Semi— field test)  Example 1 : mosquito evasion test (Semi—field test)
모기 기피 실험  Mosquito evasion experiment
계피 초임계 추출물의 모기 실험 180 X 60 X 60 cm (가로 X세로 X높이)의 직사각형의 아크릴 상자를 제작하여 칸막이를 Mosquito Experiment with Cinnamon Supercritical Extract A rectangular acrylic box of 180 x 60 x 60 cm (width x height x height) was fabricated to provide
25 이용하여 동일한 크기의 상자 세 개를 각각 나누어 케이지 A, 케이지 B, 케이지 C 로 구분하였다 (도 1). 케이지 B 에는 지름 20 cm 의 구멍을 양쪽으로 각각 만들어 케이지 A, 케이지 C 로 모기가 이동할 수 있도록 하였다. 케이지 A 에는 계피 초임계 추출물, IR 3535, IR 3535 유도체를 흔합하여 배치하고 케이지 C 에는 대조구 (70% EtOH)를 두고 냄새가 고르게 ᅵ 3.으ᅳ-퍼지도톡 약 10 분 정도 방치한 다음 케이지 B에 칸막이를 열어 30 분 후에 각각의 케이지의 모기의 마리 수를 측정하였다ᅳ LJH-1-58의모기 기피효과 Three boxes of the same size were divided into cages A, cage B, and cage C using 25 (FIG. 1). Cage B has holes with a diameter of 20 cm on each side to allow mosquitoes to move in cage A and cage C. Place a mixture of cinnamon supercritical extract, IR 3535, IR 3535 derivatives in cage A, and place a control (70% EtOH) in cage C. Evenly smell. 30 minutes after opening a partition in B, the number of mosquitoes in each cage was measured. Mosquito repellent effect of LJH-1-58
5, 10% 농도의 LJH-1-58 과 24%의 DEET 의 빨간집모기에 대한 기피력올 관찰한 결과는 표 1 에 나타내었다. 1-2 분 경과 후 1OT의 LJH-1- 58 에서 높은 기피력을 보였으며, 4-5 분 경과 후까지도 기피력이 지속됨을 확인하였다. 10%의 UH-1-58 과 24% DEET 의 기피력이 유사하게 나타난 것으로 보아 LJH-1-58 은 DEET 를 대체할 수 있는 IR 3535 의 새로운 합성물질로 사용가능 할 것이다. 또한 흰줄숲모기에서도 약 90%의 기피력을 보여 (표 2) 두 종의 모기 모두에 LJH-1-58의 적용이 가능하다.  Table 1 shows the results of observation of repellent activity on the LJH-1-58 at 5% and 10% concentration of DEET at 24%. After 1-2 minutes, 1OT of LJH-1-58 showed high repelling force, and it was confirmed that repelling force persisted even after 4-5 minutes. The similarity of 10% UH-1-58 and 24% DEET avoidance suggests that LJH-1-58 could be used as a novel compound of IR 3535 to replace DEET. In addition, white-row mosquitoes showed about 90% repellency (Table 2). LJH-1-58 can be applied to both mosquitoes.
【표 1] [Table 1]
IR 3535유도체 (LJH-l-58)의 빨간집모기 기피 효과  Respiratory Effect of IR 3535 Derivative (LJH-l-58)
Figure imgf000012_0002
Figure imgf000012_0002
1} 기피 효과 = 100 X (대조군에서 바이팅한
Figure imgf000012_0001
1} Repelling effect = 100 X (bited from control)
Figure imgf000012_0001
바이팅한 모기 수) / 대조군에서 바이팅한 모기 수 Mosquito bites) / number of mosquito bites in the control group
2)24%디에틸틀루아마이드 (DEET) 2 ) 24% Diethyl Toluamide (DEET)
【표 2】 Table 2
IR 3535유도체 (LJH-1-58)의 흰즐숲모기 기피 효과  IR 3535 derivative (LJH-1-58) avoids white mosquitoes
Figure imgf000012_0003
Figure imgf000013_0001
Figure imgf000012_0003
Figure imgf000013_0001
LJH-1-58및 계피초임계오일의모기 기피효과 Mosquito Repellent Effects of LJH-1-58 and Cinnamon Supercritical Oil
1 5 10% 계피 초임계 오일 및 1% 계피 초임계 오일과 10% IR 3535 흔합물, 1% 계피 초임계 오일과 10% LJH-1-58 흔합물의 방향 기피 실험의 결과는 표 3 과 같이 나타났다. 모기를 방사한후 30 분 동안 케이지 Β 에서 계피 초임계 오일이 있었던 케이지 Α 로 이동한 모기는 오일의 농도가 증가할수록 20¾> 18.75%, 8.57%로 총 마릿수가 감소하였다. 또한 1 )의 계피 초임계 오일과 10%의 IR 3535 및 LJH-1-58 각각의 흔합물에 대해 기피활성을 관찰한 결과, 케이지 A 로 이동한 모기의 총 마릿수는 IR 3535 흔합물에서 12.9% LJH-1-58 흔합물에서 7.4%의 수준으로 나타나 계피 초임계 오일과 LJH-1-58 의 흔합물이 방향성 및 모기 기피효과에서 아주 우수한 활성올 가짐을 확인하였다.  1 5 The results of the fragrance experiments of 10% cinnamon supercritical oil and 1% cinnamon supercritical oil, 10% IR 3535 mixture, 1% cinnamon supercritical oil, and 10% LJH-1-58 mixture are shown in Table 3. . Mosquitoes that migrated from cage Β to cage A with cinnamon supercritical oil for 30 minutes after spinning mosquitoes decreased their total number of grains to 20¾> 18.75% and 8.57% as the oil concentration increased. In addition, respiratory activity was observed in the cinnamon supercritical oil of 1) and 10% of IR 3535 and LJH-1-58, respectively, and the total number of mars of mosquitoes transferred to cage A was 12.9% in the IR 3535 mixture. The LJH-1-58 mixture showed a level of 7.4%, indicating that the mixture of cinnamon supercritical oil and LJH-1-58 had a very good activity in fragrance and mosquito repellent effects.
【표 3} Table 3
계피 초임계 오일과 IR 3535 또는 LJH-1-58 의 흔합물의 노출 후에 모기 숫자의 변화 Changes in mosquito numbers after exposure of cinnamon supercritical oil and a combination of IR 3535 or LJH-1-58
Figure imgf000013_0002
Figure imgf000013_0002
계피 초임계 오일 (400 bar, 35 °C). Cinnamon supercritical oil (400 bar, 35 ° C).
계피 초임계 오일 (400 bar, 35 °C) 1% + 10% IR 3535. Cinnamon supercritical oil (400 bar, 35 ° C) 1% + 10% IR 3535.
Λ 초임계 오일 (400 bar, 35 °C) 1% + 10% LJH-1-58. 실시예 2: 피부 안정성 평가 (단회경구투여독성 시험) Λ supercritical oil (400 bar, 35 ° C) 1% + 10% LJH-1-58. Example 2: Evaluation of Skin Stability (Single Oral Dose Toxicity Test)
개요 summary
본 시험에서는 기피제 (LJH-1-58)를 피부에 적용할 경우 안전한가 여부를 평가하기 위해, 「의약품등의 독성시험기준」 (식품의약품안전청 고시 제 2009-116 호), 「기능성화장품등의 심사에 관한 규정」 (식품의약품안전청 고시 제 2009-166 호) 및 In this study, in order to assess whether the repellent (LJH-1-58) is safe when applied to the skin, the screening of functional cosmetics, etc. Regulations pertaining to the KFDA Notification No. 2009-166) and
「비임상시험관리기준」 에 준하여 단회투여독성, 피부일차자극, 안점막자극 피부감작성 유발여부에 대해 실험을 실시하였다. 시험계 In accordance with the Non-Clinical Study Control Criteria, experiments were conducted to determine whether single-dose toxicity, primary skin irritation and ocular mucosal irritation were caused. Test system
6주령 ICR마우스를 입수 (효창사이언스, 한국)하여 7주령에 물질올 투여하였다. 실험에 이용한 동물은 총 18 마리 (웅성: 9 마리, 자성: 9 마리)였으며, 일주일간 검역 및 적응기간을 가지며 이 기간 동안 매일 관찰을 실시하여 건강한 동물만을 시험에 사용하였다. 시험방법  Six-week-old ICR mice were obtained (Hyochang Science, Korea) and administered at seven weeks of age. A total of 18 animals (9 males and 9 females) were used for the experiments, and they had a weekly quarantine and adaptation period, and were observed daily during this period, and only healthy animals were used for the test. Test Methods
동물을 검역, 적웅기간 중의 체중을 기초로 하여 선별한 후 군분리 당일의 체중을 기초로 하여 무작위법으로 각 군의 평균체중이 가능한 한 균등하도록 군을 구성하였다. 군당 마릿수는 암수 각 3마리씩으로 할당하여 실험을 실시하였다. 개체식별은 꼬리 표식법으로 하였으며, 케이지당 3 마리씩 수용하였다. 투여전일 절식 (14-16 시간 정도)한 후, 존데를 이용하여 시험물질을 경구투여하였다.  Animals were screened based on body weight during quarantine and red-eye periods, and then groups were constructed so that the average weight of each group was as evenly as possible by random method based on body weight on the day of group separation. The number of digits per group was assigned to three male and female experiments. Individual identification was by tail labeling and 3 animals per cage were housed. After fasting (about 14-16 hours) the day before administration, the test substance was orally administered using sonde.
【표 4】 Table 4
시험군의 구성 Composition of test group
Figure imgf000014_0001
Figure imgf000015_0001
관찰및 검사항목
Figure imgf000014_0001
Figure imgf000015_0001
Observation and Inspection Items
투여당일은 투여 후 30분, 1시간, 2시간, 3시간, 4시간, 5시간, 6 시간 까지는 매시간 마다 관찰하고, 투여 다음날부터 하루에 1 회씩 매일 14일간 관찰함을 원칙으로 하였다. 약물에 의한 일반상태의 변화, 중독증상 및 폐사여부를 관찰하였다. 체중은 투여 직전, 투여 후 1 일, 3 일, 7 일 및 부검당일 부검 직전 (14일)에 측정하였다. 시험결과  On the day of dosing, every 30 minutes, 1 hour, 2 hours, 3 hours, 4 hours, 5 hours, 6 hours after the administration was observed every hour. Changes in general condition, intoxication symptoms and mortality by drugs were observed. Body weights were measured immediately prior to dosing, 1 day, 3 days, 7 days after dosing and immediately before autopsy (14 days). Test result
기피제 100%를 투여한 군은 투여당일에는 별다른 이상을 보이지 않았지만, 투여 후 1 일 경과 후 모두 폐사하였다. 기피제 50¾> 투여군과 용매투여군은 실험기간 중 특이한 임상증상을 보이거나 사망한 동물이 없었다 (표 5-10) .  The group administered 100% of the repellent showed no abnormality on the day of administration, but all died 1 day after administration. The repellent group and the solvent-administered group did not show any specific clinical symptoms or died animals during the experiment (Table 5-10).
본 시험조건에서 기피제는 단희투여경구독성 시험결과 100% 원액을 10 ml /kg 으로 투여할 경우 모두 폐사하였으며, 50% 희석액 10 ml/kg 를 투여 한 경우는 모두 생존하였으므로, 본 시험물질의 LD50 치는 100% 원액 기준으로 5-10 ml /kg 정도로 추정된다. In the present test conditions repellents are hayeoteumeuro when administered with, 50% dilution 10 ml / kg was our both when administered as a 100% stock solution toxicity test danhui orally administered 10 ml / kg, all survived, LD 50 of the test substance Value is estimated at 5-10 ml / kg based on 100% stock solution.
【표 5】 Table 5
시험 결과 Test result
Figure imgf000015_0002
【표 6】
Figure imgf000015_0002
Table 6
시험 물질을 경구 투여한 ICR마우스의 치사율 Mortality of ICR Mice Administered Orally with Test Substance
Figure imgf000016_0001
Figure imgf000016_0001
【표 7】 Table 7
시험 물질을 경구 투여한 ICR마우스의 체중 변화 Weight Change in ICR Mice Orally Administered with Test Substance
Figure imgf000016_0002
Figure imgf000016_0002
* 모든 값들은 표준편차 (士 S.D.)로 나타냄.  * All values are expressed as standard deviation (士 S.D.).
^룹 Hi물^는— 3 Ι였ᅩ음—.ᅳ 【표 8】 ^ Group Hi water ^ was-3 —. Table 8
PEG-400을 경구 투여한 ICR마우스 (웅성 )의 임상적 소견  Clinical Findings of ICR Mice (Men) with oral PEG-400
Figure imgf000017_0001
Figure imgf000017_0001
【표 9】 Table 9
기피제 (LJH-1-58) 50%를 경구 투여한 ICR마우스 (자성)의 임상적 소견 Clinical Findings of ICR Mice (Magnetic) Orally Administered with 50% Repellent (LJH-1-58)
Figure imgf000017_0002
Figure imgf000017_0002
Figure imgf000018_0001
실시예 3: 피부 안정성 평가 (안점막자극시험)
Figure imgf000018_0001
Example 3: Evaluation of Skin Stability (Eye Membrane Stimulation Test)
시험계 Test system
3 개월령 NZ 흰색 토끼 (샘타코 코리아)를 구입하고, 일주일간 검역 및 적응기간을 가지며 이 기간 동안 매일 관찰을 실시하여 건강한 동물만을 시험에 사용하였다. 시험방법  Three-month-old NZ white rabbits (Samtaco Korea) were purchased and had a week-long quarantine and acclimatization period during which daily observations were used to test only healthy animals. Test Methods
검역 및 적웅기간 중의 체중올 기초로 하여, 안검사 후 각막 손상 등 안구에 이상이 없는 동물을 선별한 후, 임상 및 체중증가 등에 이상이 없으며 상태가 양호한 건강한 동물을 군 분리 당일의 체중과 주령을 기초하여 무작위법으로 각 군의 평균체중이 균등하도록 군을 구성하였다. 4 마리 중 2 마리는 오른쪽 눈에 시험물질을 점안하고, 왼쪽 눈은 무처치 대조안으로 두었으며, 나머지 2 마리는 오른쪽 눈은 시험물질 점안 후 세척군, 왼쪽 눈은 대조물질인 PEG-400을 점안하였다 (도 3).  On the basis of weight during the quarantine and red-eye period, animals with no abnormalities in the eye such as corneal damage are selected after eye examination, and healthy animals with no abnormalities in clinical and weight gain and healthy condition are determined by weight and age on the day of group separation. On the basis of the random method, groups were composed so that the average weight of each group was equal. Two out of four eyes were given the test substance in the right eye, and the left eye was left untreated. The other two eyes were given the test group after the instillation of the test substance in the right eye and PEG-400, the left eye in the control group. (FIG. 3).
【표 11】 Table 11
시험군의 구성 Composition of test group
Figure imgf000019_0001
시험물질 농도 및 투여량
Figure imgf000019_0001
Test Substance Concentration and Dosage
시험물질은 PEG-400 에 희석하여 10% 농도로 안구당 0.1 ml 씩 투여하였다. 세척군 안구는 시험물질 점안 30 초 후에 미온 생리식염수를 이용하여 층분히 세안하였다. 관찰및검사항목 Test substance was diluted in PEG-400 and administered 0.1 ml per eye at 10% concentration. Washing eyes were thoroughly washed with warm physiological saline 30 seconds after eye drops. Observation and Inspection Items
시험기간 동안 매일 일반증상 및 사망여부를 관찰하였다. 적용부위의 관찰적용부위는 시험물질 점안 후 1 시간, 24 시간, 48 시간, 72 시간째 및 4 일, 7 일째에 관찰을 하였고 안점막 반웅의 평가는 의약품등의독성시험 기준의 안구 병변의 등급에 따라 평점으로 평가하였다. 결과의 해석  General symptoms and deaths were observed daily during the test period. Observation site of applied area was observed at 1 hour, 24 hours, 48 hours, 72 hours and 4 days, 7 days after instillation of the test substance. According to the rating. Interpretation of results
반응 평가에 의한 결과의 판정은 일반적으로 많이 사용되는 Draize 안자극 구분표를 따랐다.  Judgment of the results by response evaluation followed the commonly used Draize eye irritation table.
【표 12】 Table 12
안자극 결과 판정표 Eye stimulation result judgment table
Figure imgf000020_0001
Figure imgf000020_0001
a) A.O.I. (Acute ocular irritation index): 평균안점막 자극지수 가운데 최대값 a ) AOI (Acute ocular irritation index): maximum value of mean ocular irritation index
b) M.O.I. (Mean ocular irritation index): 총 스코어 /실험 동물 수 c) 7 일 1.0.1. (Individual ocular irritation index): 7 일째 각 동물의 스코어 시험결과 b ) Mean ocular irritation index (MOI): Total score / number of experimental animals c) 7 days 1.0.1. (Individual ocular irritation index): score of each animal on day 7 Test result
실험기간 중 특이한 임상증상을 보이거나 사망한 동물은 없었다. 기피제 (LJH-1-58) 10%의 비세안군 자극지수 (A.0.1)는 2 로 '사실상 무자극' 을 나타내었으며, 세안군은 0 으로 '무자극' 을 나타내었다. 용매로 사용된 PEG-400 의 자극지수 (A.0.1)는 3 으로 '사실상 무자극' 을 나타내었다. 기피제 10%의 비세안군 자극은 24 시간 이후 모두 없어졌으며, 용매인 PEG-400 의 발적은 일부 남아 있었으나 48 시간 이후에는 모두 회복되었다 (도 4).  No animals showed unusual clinical symptoms or died during the study. Repellent (LJH-1-58) 10% of non-cleansing group stimulation index (A.0.1) was 'virtually non-irritating' with 2, and the facial cleansing group was 'non-irritating' with 0. The stimulus index (A.0.1) of PEG-400 used as a solvent was 3, indicating 'virtually non-irritating'. The non-eye washing group stimulation of 10% of the repellent disappeared after 24 hours, and redness of the solvent PEG-400 remained, but recovered after 48 hours (FIG. 4).
【표 13] Table 13
시험 결과 Test result
Figure imgf000021_0001
본 시험 결과, 기피제 10%는 급성안점막 자극지수가 5 이하이므로 안점막 자극을 유발하지 않는 것으로 판단된다. 초기의 약한 자극은 용매로 사용된 PEG-400의 영향일 것으로 추정된다.
Figure imgf000021_0001
As a result of this test, 10% of repellents do not induce ocular mucosal irritation because acute mucosal irritation index is 5 or less. The initial mild stimulus is believed to be the effect of PEG-400 used as solvent.
【표 14】 Table 14
기피제 (LJH-1-58)의 눈 자극성 시험 결과 Eye irritation test results of repellent (LJH-1-58)
Figure imgf000021_0002
Figure imgf000021_0002
Figure imgf000022_0001
Figure imgf000022_0001
Ϊ66800/ΖΪ0ΖΗΜ/Χ3<1 실시예 4: 피부 안정성 평가 (피부 일차자극시험) Ϊ66800 / ΖΪ0ΖΗΜ / Χ3 <1 Example 4 Skin Stability Assessment (Skin Primary Stimulation Test)
시험계 Test system
3 개월령 NZ 흰색 토끼 (샘타코 코리아)를 구입하고, 일주일간 검역 및 적웅기간을 가지며 이 기간 동안 매일 관찰을 실시하여 건강한 동물만을 시험에 사용하였다. 시험방법  Three-month-old NZ white rabbits (Samtaco Korea) were purchased and had a week-long quarantine and red-eye period during which daily observations were used to test only healthy animals. Test Methods
검역 및 적응기간 중의 체중을 기초로 하여, 등 부위 제모 시 피부 상태가 양호한 동물을 시험에 무작위법으로 군을 구성하였다. 4 마리 중 2마리는 기피제 (LJH-1-58) 10%를, 2마리는 기피제 50%를 도포하였다.  Based on body weight during the quarantine and adaptation periods, animals with good skin condition at the back of the epilator were randomized to the test group. Two of the four animals received 10% repellent (LJH-1-58) and two 50% repellent.
【표 15】 Table 15
시험군의 구성 Composition of test group
Figure imgf000023_0001
Figure imgf000023_0001
시험물질 처치 Test substance treatment
토끼 등 부위 털을 가로세로 약 10 cm 이상 되도록 제모한 후, 왼쪽은 시험물질 적용부위, 오른쪽은 대조물질 적용부위로 하고, 각 적용부위는 찰과 부위와 바찰과 부위를 두어 실험을 실시하였다. 시험물질은 적절한 농도로 조제하여 각 사이트 당 0.5 ml 씩 도포하여, 24시간 폐쇄 첩포 하였다 (도 5). 관찰 및 검사항목  After shaving the hair on the back of the rabbit to be more than about 10 cm in length, the experiment was conducted on the left side of the test substance application site and the right side of the control material application site. The test substance was prepared at an appropriate concentration, 0.5 ml of each site was applied, and closed patch for 24 hours (FIG. 5). Observation and Inspection Items
일반상태 및 사망여부를 매일 관찰하였으며, 체중은 군분리 시와 72 시간째에 측정하였다. 시험물질 적용부위는 적용 24 시간째와 72 시간째에 관찰을 하며 피부 반웅의 평 7} 一 「의약품등의독성시험기준」 (식품의약품안전청고시
Figure imgf000024_0001
피부반웅의 평가기준에 따라 평점으로 평가하였다.
General condition and death were observed daily, and body weight was measured at group separation and at 72 hours. The site of application of the test substance is observed at 24 hours and 72 hours after application. `` Toxicity Test Standards for Drugs '' (Notice of KFDA)
Figure imgf000024_0001
The evaluation was performed according to the evaluation criteria of skin reaction.
【표 16] Table 16
피부반응의 평가기준 Evaluation criteria of skin reaction
Figure imgf000024_0002
결과의 해석
Figure imgf000024_0002
Interpretation of results
피부일차자극지수 (Ρ.Ι.Ι.)는 시험물질 적용 후 24 시간째와 72 시간째의 홍반과 부종 평점에 의하여 산출하였다. 찰과 부위와 비찰과 부위 각각에 홍반 평점의 평균과 부종 평점의 평균을 구하며 24 시간째의 결과와 72 시간째의 결과의 평균값을 피부일차자극지수로하여 피부일차자극 결과 판정표에 의하여 결과를 판정하였다.  The skin primary stimulation index (Ρ.Ι.Ι.) was calculated by erythema and edema grade at 24 hours and 72 hours after application of test substance. The mean of erythema score and edema score were calculated for each of the abrasion site and the non-brain site, and the results were judged by the skin primary stimulation index based on the skin primary stimulation index as the average value of the results at 24 hours and at 72 hours. It was.
【표 17】 Table 17
피부일차자극 결과 판정표
Figure imgf000024_0003
Figure imgf000025_0001
Skin Primary Stimulation Result Determination Table
Figure imgf000024_0003
Figure imgf000025_0001
시험결과 Test result
실험기간 중 특이한 임상증상을 보이거나 사망한 동물은 없었다. 기피제 10%의 P.I.I.는 0.13 으로 무자극 범위에 해당하므로 사용가능하다. 기피제 50%의 P.I.I.는 0.13 으로 무자극 범위에 해당하므로 사용가능하다 (표 19-21). 시험물질 및 용매 처치부위 중 찰과 부위에서 24 시간째에 일부 약한 흥반이 관찰되었으나, 이는 물리적 자극에 의한 일시적인 자극으로 판단되며, 곧바로 정상으로 회복됨이 관찰되었다 (도 6).  No animals showed unusual clinical symptoms or died during the study. P.I.I. of 10% repellent is 0.13 and can be used because it falls within the non-irritating range. P.I.I. of 50% repellent is 0.13 and can be used because it falls within the non-irritating range (Tables 19-21). Some mild hemorrhage was observed at the scratch and site of the test substance and solvent treatment site at 24 hours, but it was judged to be a temporary stimulus by physical stimulus and immediately recovered to normal (FIG. 6).
【표 18】 Table 18
시험 결과 Test result
Figure imgf000025_0002
이상의 결과, 본 시험조건에서, 실험기간
Figure imgf000025_0002
Above results, under the test conditions, the experimental period
보이거나 사망한 동물은 없었으며, 기피제 10% No animals were seen or died, 10% repellent
측면에서 안전한 원료라 판단된다. We believe it is a safe raw material.
【표 19】 Table 19
기피제 (LJH-1-58) 10%의 일차자극 시험 결과 Repellent (LJH-1-58) 10% primary stimulation test results
Figure imgf000025_0003
纏 0 0 1 0 0 0 .0 0 0 0 1 0 ο. 0 0 0 圖 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Figure imgf000025_0003
纏 0 0 1 0 0 0 .0 0 0 0 1 0 ο. 0 0 0 圖 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 00 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0
0 0 0.5 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.5 0 0 0 0 0 0 0 0.5 0 0 0 0 0
0. 5 0. 5  0.5 0 0.5
0. 13 0. 13 0. 13 0. 13
【표 20] Table 20
기피제 (LJH-1-58) 50%의 일차 자극 시험 결과 50% primary irritation test results of repellent (LJH-1-58)
Figure imgf000026_0001
실시예 5: 기니 피그를 이용한 피부 감작성 시험 (GPMD
Figure imgf000026_0001
Example 5 Skin Sensitization Test Using Guinea Pigs (GPMD)
시험계 Test system
체중 250-300 g 의 Hartley albino 기니 피그를 구입 (샘타코 코리아)하였다. 일주일간 검역 및 적웅기간을 갖고, 이 기간 동안 체중증가 및 일반증상에 이상이 없는 건강한 동물 중 등부분을 제모하였을 때 상태가 양호한 것을 시험에 사용하였다. 검역 및 적응 기간 증 이상이 없는 동물 중 등 부분을 제모하여 피부 상태가 양호한 건강한 동물을 선별한 후, 군 분리 당일의 체중을 기초로 하여 평균 체중이 가능한 균등하도록 군을 구성하였다. 시험방법 Hartley albino guinea pigs weighing 250-300 g were purchased (Samtaco Korea). Healthy animals with a week-long quarantine and red-eye period during which weight gain and general symptoms were not removed were used for the test. After removing the quarantine and adaptation period, the back of the animal is epilated to select healthy animals with good skin condition. Based on the weight on the day of separation, the groups were configured so that the average body weight was as even as possible. Test Methods
인덕션은 시험 실시 4 시간 전 등 윗 부위 (견갑 상부)를 털을 3 X 3 cm 크기로 제모하여 사용하였고, 챌린지는 시험 실시 24 시간 전에 인덕션 부위 아래의 등 부위 (dorso-thoracic, lumbar region)의 털을 4 X 6 cm 크기로 제모한 후 시험 당일 전기 면도기로 나머지 털을 제거한 후 사용하였다. 1 차 인덕션은 각각의 시험군의 기니픽 견갑간부에 시료, FCA, 시료 + FCA를 2 열로 0.1 ml 씩 피내 주사하였다. 2차 인덕션은 일주일 후 FCA 주사 동일 부위를 제모한 뒤 10% SLS (용매: 페트로라텀)를 주사부위에 도포하고, 24 시간 후 동일부위에 시험 물질 0.1 ml 을 투여한 지름 1.5 X 1.5 cm 의 패치 4 개에 0.1 ml 를 도포하여 48 시간 폐쇄 첩포하였다. 챌린지는 마지막 인덕션 10 일 이후, 피부 일차자극이 없는 농도로 마리당 좌우 각 2 사이트씩 24 시간 폐쇄 첩포하여 피부 흥반, 부종을 관찰 하였다 (도 7). 시험군 구성 【표 21】  Induction was performed using the upper part of the back (the upper part of the shoulders) at 3 x 3 cm hair removal 4 hours before the test. The hair was removed to a size of 4 × 6 cm and used after removing the remaining hair with an electric razor on the test day. Primary induction was intradermal injection of 0.1 ml of sample, FCA, and sample + FCA into the guinea pig scapula in each test group. Secondary induction is a week after depilation of the same site of FCA injection, 10% SLS (solvent: petrolatum) is applied to the injection site, and after 24 hours, a patch of 1.5 X 1.5 cm in diameter in which 0.1 ml of the test substance is administered to the same site. 0.1 ml was applied to four and closed patched for 48 hours. Challenge 10 days after the last induction, the skin was closed for 24 hours at 2 concentrations each left and right at concentrations without primary stimulation of the skin to observe the skin growth and edema (Fig. 7). Test Group Configuration 【Table 21】
시험군의 구성 Composition of test group
Figure imgf000027_0001
Figure imgf000028_0001
관찰및 검사항목
Figure imgf000027_0001
Figure imgf000028_0001
Observation and Inspection Items
시험 기간 동안 임상증상과 사망여부를 관찰하였다. 시험물질에 대한 챌린지를 실시한 다음, 시험물질 첩포 제거 후 24, 48 시간째에 흥반 및 부종 반웅 등의 자극성을 유무를 판단하였다. 필요할 경우에는 전기면도기를 이용하여 제모 한 후 검사하였으며, 제모 했을 경우에는 약 1시간 정도 시간이 지난 다음 (2시간 이내) 검사를 실시하였다.  Clinical symptoms and death were observed during the trial. After challenge with the test substance, it was determined whether there was irritation such as hemorrhage and edema reaction at 24 and 48 hours after removing the test substance patch. If necessary, hair removal was performed using an electric razor, and when hair removal was performed, an examination was performed after about 1 hour (within 2 hours).
각 구획에서의 반응 평가는 의약품등의독성시험기준 (식품의약품안전청 고시 제 2005-60 호)을 이용하여 판정하였다 (표 23). 또한 피부감 성 유발 가능성에 대한 판정은 Kligman 의 등급을 따랐다 (표 24). 피부감작성 판정 기준표의 등급 I, II 는 사용 가능 범위로 하며 등급 III 이상은 사용불가 범위로 하였다.  The evaluation of the response in each compartment was determined using the Toxicology Test Standards (Notification No. 2005-60 of the Korea Food and Drug Administration) (Table 23). In addition, the determination of skin sensitization potential was based on Kligman's rating (Table 24). Grades I and II of the skin sensitization criteria table were made available and grades III and above were made unusable.
【표 22】 Table 22
피부 반웅의 평가 기준 의약품등의독성시험기준 Evaluation standard of skin reaction Toxicity standard of medicine
Figure imgf000028_0002
Figure imgf000028_0002
Figure imgf000028_0003
81 - 100 V 「심한 민감제 사용불가 시험결과
Figure imgf000028_0003
81-100 V `` Severe sensitizer test results not available
시험기간 동안 임상증상 및 체중변화에서 특이한 사항은 관찰되지 않았다. 기피제의 감작성 결과, 10% 및 50% 농도로 야기했을 때 감작성이 0%로 관찰되어 시험물질 사용가능 범위인 "등급 Γ 에 해당하였다. DNCB 군의 0,5% 농도에서 24 시간과 48 시간에 모두 100 )로 Kligman 의 감작성 기준표 상의 시험물질 사용불가 범위인 "등급 V" 에 해당하였으며, 0.1% 농도에서는 24 시간과 48 시간에 각각 100%, 75%로 Kligman 의 감작성 기준표 상의 시험물질 사용불가 범위인 "등급 V" 에 해당하였다. 음성대조군의 경우 용매로 감작시킨 후, 기피제 50% 및 DNCB 0.5%로 야기 시켰을 경우, 모두 자극이 관찰되지 않았다 (도 8).  Nothing unusual was observed in clinical symptoms and body weight changes during the trial. As a result of the sensitization of the repellent, sensitization was observed at 0% when caused by 10% and 50% concentrations, corresponding to the test substance available range "Grade Γ. 24 hours and 48 at 0,5% concentrations of the DNCB group. All of them corresponded to "Class V" in the range of non-use of the test substance on Kligman's sensitization criteria table at 100 hours, and 100% and 75% at 24% and 48 hours at 0.1% concentration, respectively. Corresponding to the substance unusable range, “grade V.” No negative stimulation was observed in the negative control group after sensitization with solvent and caused by 50% repellent and 0.5% DNCB (FIG. 8).
【표 24】 Table 24
챌린지 결과 Challenge result
Figure imgf000029_0001
시험기간 중 임상증상 및 체중증가 등에 이상 동물은 관찰되지 않았다. 기피제 50 및 10%는 챌린지 결과 양성율이 사용가능 범주로 평가되었다. 양성대조 물질로 사용한 DNCB 0.5 및 0.1%는 높은 김~작성을 보였다. 【표 25]
Figure imgf000029_0001
No abnormal animals were observed during clinical trials. Repellents 50 and 10% rated the outcome positive for the challenge category. DNCB 0.5 and 0.1% was used as positive control substance showed a high steam-right. Table 25
챌린지 후 치사율 Fatality rate after challenge
Figure imgf000030_0001
Figure imgf000030_0001
【표 26]  Table 26
챌린지 결과 (그룹 데이터) Challenge Results (Group Data)
Figure imgf000030_0002
이상으로 본 발명의 특정한 부분올 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적인 기술은 단지 바람직한 구현예일 뿐이며, 이에 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항과 그의 등가물에 의하여 정의된다고 할 것이다.
Figure imgf000030_0002
As described above, a specific part of the present invention has been described in detail. For those skilled in the art, the specific technology is merely a preferred embodiment, and it is obvious that the scope of the present invention is not limited thereto. Accordingly, the substantial scope of the invention will be defined by the appended claims and equivalents thereof.

Claims

【특허청구범위】 【청구항 1】 다음 화학식 1의 화합물을 유효성분으로 포함하는 곤층 기피 (insect repel lent) 조성물: Claims Claim 1 An insect repel lent composition comprising the compound of formula 1 as an active ingredient:
[화학식 1]  [Formula 1]
Figure imgf000031_0001
Figure imgf000031_0001
【청구항 2】 [Claim 2]
제 1 항에 있어서, 상기 화학식 1의 화합물은 전체 조성물에 대하여 0.1 내지 25 중량 %로 포함되는 것을 특징으로 하는 곤층 기피 조성물.  According to claim 1, wherein the compound of formula (1) characterized in that the topping layer avoiding composition, characterized in that contained in 0.1 to 25% by weight based on the total composition.
【청구항 3] [Claim 3]
제 1 항에 있어서, 상기 곤충은 모기, 파리, 개미, 벌, 귀뚜라미, 노린재, 부채벌레, 벼룩, 풍뎅이, 사마귀 또는 바퀴벌레인 것을 특징으로 하는 곤층 기피 조성물.  The method of claim 1, wherein the insects are mosquitoes, flies, ants, bees, crickets, stink bugs, fan beetle, fleas, scarabs, warts or cockroaches.
【청구항 4】 [Claim 4]
제 3 항에 있어서, 상기 곤층은 모기인 것을 특징으로 하는 곤층 기피 조성물.  4. The dope avoidance composition of claim 3, wherein the dope is a mosquito.
【청구항 5】 [Claim 5]
제 1 항에 있어서, 상기 조성물은 계피 초임계 오일을 추가적으로 포함하는 것을 특징으로 하는 곤충 기피 조성물  The insect repellent composition of claim 1, wherein said composition further comprises cinnamon supercritical oil.
【청구항 6】 [Claim 6]
제 5 항에 있어서, 상기 계피 초임계 오일은 계피를 온도 30-40°C, ᅭ압 200- 0α— bar-에서—초ᅳ임—계—추출하껴—수득한—것을 특징으—로—ᅳ하는 ^충一 기피 조성물. 6. The method according to claim 5, wherein the cinnamon supercritical oil is characterized in that the cinnamon is characterized in that the cinnamon is extracted at a temperature of 30-40 ° C at a pressure of 200-0α—bar-—supercritical—based—extracted—obtained. ^ Chungcheong avoidance composition.
【청구항 7] [Claim 7]
제 5 항에 있어서, 상기 계피 초임계 오일은 전체 조성물에 대하여 0.1 내지 20 중량 %로 포함되는 것을 특징으로 하는 곤층 기피 조성물.  6. The tortilla repellent composition of claim 5, wherein the cinnamon supercritical oil is contained in an amount of 0.1 to 20% by weight based on the total composition.
【청구항 8】 [Claim 8]
(a) 상기 제 1 항 내지 제 7 항 중 어느 한 항의 조성물의 화장품학적 유효량; 및 (b) 화장품학적으로 허용되는 담체를 포함하는 곤층 기피용 화장료 조성물.  (a) a cosmetically effective amount of the composition of any one of the preceding claims; And (b) a pharmaceutically acceptable cosmetic composition comprising a cosmetically acceptable carrier.
【청구항 9】 [Claim 9]
상기 제 1 항 내지 제 7 항 중 어느 한 항의 조성물을 피부에 도포하는 단계를 포함하는 곤충 기피 (insect repelling) 방법.  An insect repelling method comprising applying the composition of claim 1 to the skin.
【청구항 10】 [Claim 10]
상기 제 1 항 내지 제 7 항 중 어느 한 항의 조성물을 방층 효과를 얻고자 하는 영역에 적용 (applying) 하는 단계를 포함하는 곤층 기피 방법.  Claims 1 to 7 of claim 1 comprising applying the composition of any one of the claims to the area to obtain a barrier effect.
PCT/KR2012/008991 2012-02-17 2012-10-30 Composition for repelling insects comprising ir 3535 derivative as active ingredient WO2013122304A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120016232A KR101386233B1 (en) 2012-02-17 2012-02-17 Compositions for Repelling Mosquitoes Comprising IR 3535 Derivative as Active Ingredient
KR10-2012-0016232 2012-02-17

Publications (1)

Publication Number Publication Date
WO2013122304A1 true WO2013122304A1 (en) 2013-08-22

Family

ID=48984398

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/008991 WO2013122304A1 (en) 2012-02-17 2012-10-30 Composition for repelling insects comprising ir 3535 derivative as active ingredient

Country Status (2)

Country Link
KR (1) KR101386233B1 (en)
WO (1) WO2013122304A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255253B1 (en) * 1997-08-18 2001-07-03 Cognis Deutschland Gmbh Microemulsions
KR20030087445A (en) * 2002-05-10 2003-11-14 대한민국(서울대학교 총장) Natural composition of repelling mosquitoes
US20080319015A1 (en) * 2005-12-22 2008-12-25 Hans-Werner Gruenewald Insect Repellent Mixture

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070076802A (en) * 2006-01-20 2007-07-25 (주)원텍 Antimicrobial compositions and rood packaging sheet using natural extracts
JP5057856B2 (en) 2007-06-19 2012-10-24 大日本除蟲菊株式会社 Pest repellent for human body

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6255253B1 (en) * 1997-08-18 2001-07-03 Cognis Deutschland Gmbh Microemulsions
KR20030087445A (en) * 2002-05-10 2003-11-14 대한민국(서울대학교 총장) Natural composition of repelling mosquitoes
US20080319015A1 (en) * 2005-12-22 2008-12-25 Hans-Werner Gruenewald Insect Repellent Mixture

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CILEK, J. E. ET AL.: "Comparative efficacy of IR3535 and DEET as repellents against adult Aedes Aegypti and Culex Quinquefasciatus", J. AM. MOSQ. CONTROL ASSOC., vol. 20, no. 3, 2004, pages 299 - 304 *

Also Published As

Publication number Publication date
KR20130094945A (en) 2013-08-27
KR101386233B1 (en) 2014-04-18

Similar Documents

Publication Publication Date Title
JP2002508949A (en) Composition comprising honey and at least one essential oil and / or at least one essential oil derivative
KR102309958B1 (en) A cosmetic composition for skin improvement comprising bulb extract
JP2009510100A (en) Preganic acid insect repellent
KR102330930B1 (en) Hair cosmetic composition for preventing hair loss, promoting hair growth and protecting scalp comprising natural herb extract
KR20140115400A (en) Composition of scalp care for prevention of depilation and improvement of hair growth comprising Rhus javanica L. Extracts
KR20190080011A (en) Composition for mosquito repellent containing naturally extracting components
EP3834829A2 (en) Compatible solute or solute mixture (preferably ectoin or ectoin-derivatives) for use in the prevention or treatment of diseases having barrier defects in epithelial tissues
EP2081428B1 (en) Antipediculosis composition having a lice-suffocating activity
KR101732906B1 (en) Skin care and atopic dermatitis cosmetic compositions containing asiatic pennywort extract, magnolia bark extract, hiba arborvitae branch extract, eucalyptus oil and borage seed oil
CN110072516B (en) Cosmetic composition comprising extracts of Chinese medicinal materials as effective ingredients
US20180035675A1 (en) Composition of a novel topical insect repellent powder formulation
CN103637920B (en) A kind of child dispels the antipruritic mosquito-repellent perfume of miliaria
JPH10139676A (en) Antiallergic composition for skin lotion
Norten Neem: India's miraculous healing plant
WO2005025587A1 (en) Composition comprising ginkgolides and bilobalide
JP4501025B2 (en) Skin tick control agent
DE60132887T2 (en) (-) GUAIOL, METHOD OF CREATION AND USE
KR20200073832A (en) trifoliate orange extracted by Tincture How to make odor reducing animal shampoo using this
WO2013122304A1 (en) Composition for repelling insects comprising ir 3535 derivative as active ingredient
US20210400960A1 (en) Insect repellent composition
JPH0640933A (en) Antiinflammatory agent
KR20140114709A (en) Composition for Improving Skin Conditions Comprising Boehmeria spicata (Thunb.) Thunb Extract
JPH08176006A (en) Living body-aging preventive and composition for skin
KR101764879B1 (en) Hair growth activating composition
JPH11269029A (en) Preparation for external use for skin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12868747

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12868747

Country of ref document: EP

Kind code of ref document: A1